ALLAY, NCT00219141 / 2005-000856-34: Aliskiren in Combination With Losartan Compared to Losartan on the Regression of Left Ventricular Hypertrophy in Overweight Patients With Essential Hypertension |
|
|
| Completed | 3 | 460 | US, Europe, RoW | Aliskiren 150/300 mg, Losartan 50/100 mg, Aliskiren placebo, Losartan 50/100 mg placebo | Novartis Pharmaceuticals | Hypertension, Left Ventricular Hypertrophy, Overweight | 11/07 | 11/07 | | |
